HHS-NIH-NIAID-BAA2023-1 - Amendment Twelve.pdf

HHS-NIH-NIAID-BAA2023-1

Page 1 of 3 Amendment Twelve (12)

NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES (NIAID)

2023 DMID Omnibus Broad Agency Announcement (BAA):

No. HHS-NIH-NIAID-BAA2023-1

Solicitation Amendment Twelve (12)

Issuing Office: OFFICE OF ACQUISITIONS

National Institute of Allergy and Infectious Diseases (NIAID)

5601 Fishers Lane, Room 3D38, MSC 9821

Bethesda, MD 20892-9821

Solicitation Number: HHS-NIH-NIAID-BAA2023-1

Date of Solicitation Issuance: January 11, 2023

Date of Amendment Twelve Issuance: April 6, 2023

Number of Pages: Three (3)

Proposal Due Dates: The hour and date specified for receipt of offers for each

Research Area remains unchanged:

RESEARCH

AREA

TITLE PROPOSALS DUE*

Development of Vaccine Candidates for

Biodefense and Emerging Infectious

Diseases

April 11, 2023

Development of Therapeutic Candidates for Biodefense, Antimicrobial Resistant

(AMR) Infections and Emerging

Infectious Diseases

The Antiviral Program for Pandemics

(APP): Development of Antivirals for

Specific RNA Viral Families of

Pandemic Potential

March 13, 2023

Development of In Vitro Diagnostics for

Biodefense, Antimicrobial Resistant

Infections (AMR), and Emerging

Infectious Diseases

* Proposals must be received before 3:00 PM Eastern Time on the date specified herein.

Page 2 of 3 Amendment Twelve (12)

Contracting Office Points of Contact:

Primary Contact:

Swee L. Teo, Contracting Officer

Email: teosl@niaid.nih.gov

Phone: 240-669-5173

Secondary Contact:

Ebony Taylor, Contract Specialist

Email: ebony.taylor@nih.gov

Phone: 240-292-0668

Offerors MUST acknowledge receipt of the amendment by Amendment number(s) and date of the amendment. Failure to receive your acknowledgment of this amendment may result in the rejection of your proposal.

Except as provided herein, all terms and conditions of the solicitation remain unchanged and in full force and effect.

PURPOSE OF AMENDMENT TWELVE (12)

The purpose of Amendment Twelve (12) is to:

I. Provide the NIAID’s response to questions received regarding the solicitation. The responses are offered for information only and do not modify or become part of this solicitation. Additional amendments may be provided as needed to address further questions and their related responses.

Please note, in the questions/responses below, specific organizational names have been removed or replaced where possible as well as other minor adjustments.

I. GOVERNMENT’S RESPONSES TO QUESTIONS RECEIVED REGARDING THIS

SOLICATION ARE AS FOLLOWS:

A. General Questions applicable to all Research Areas:

Question 1: Does a subcontract or consultant need to provide the following information in the

Letter of Support:

Contact information for our cognizant U.S. Government field audit office:

Name: xxx

Address: xxx

Phone Number: xxx

Email: xxx

Response: If an offeror proposes a fixed-price type agreement with its subcontractor or consultant, the above information is not required; however, if an offeror proposes a cost-reimbursement type agreement with its subcontractor or consultant, the Letter of Support must provide the above information based on the cognizant U.S. Government field audit office that negotiated the subcontractor or consultant’s established indirect cost rate agreement. If the subcontractor or consultant has not negotiated an indirect cost rate agreement with a cognizant mailto:teosl@niaid.nih.gov mailto:ebony.taylor@nih.gov

Page 3 of 3 Amendment Twelve (12)

U.S. Government field audit office, the Letter of Support must indicate that the above information is unavailable. For more information, see Question 2 under Research Area (RA) 004 of

Amendment Three.